MYC and neoplasm: They spatially validated the demarcation of tumor regions, characterized by high expression of epithelial markers, and stromal regions, marked by elevated fibroblast markers and revealed distinct pathway activities specific to different spatial niches: tumor regions were enriched for cell proliferation pathways such as E2F and MYC targets, whereas stromal regions were enriched for inflammatory response and EMT (67).